Chemistry, Manufacturing, and Controls (CMC) Support

The contract involves providing comprehensive Chemistry, Manufacturing, and Controls (CMC) development services for medical countermeasures (MCMs). Key activities include process optimization, analytical validation, stability testing, and manufacturing scale-up conducted under current Good Manufacturing Practices (cGMP). These services are essential for ensuring product quality, efficacy, and regulatory compliance throughout the drug development lifecycle. Issued by the National Institutes of Health/NIAID under the Department of Health and Human Services, the subcontract aligns with NAICS code 325412, which pertains to pharmaceutical manufacturing. The deadline for proposal submissions is June 2, 2026. While specific location details and points of contact are not provided, the contract emphasizes the need for expert support in CMC activities critical to advancing public health initiatives through the development of effective medical countermeasures.